S Squared Technology, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
S Squared Technology, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$12,552,940
-1.2%
108,2150.0%6.77%
+7.7%
Q2 2023$12,704,441
+46.6%
108,2150.0%6.29%
+22.2%
Q1 2023$8,663,693
+1.1%
108,2150.0%5.14%
-11.3%
Q4 2022$8,572,792
+13.7%
108,2150.0%5.80%
+5.1%
Q3 2022$7,543,000
+6.2%
108,2150.0%5.52%
+12.2%
Q2 2022$7,105,000
-1.3%
108,2150.0%4.92%
+36.9%
Q1 2022$7,201,000
+8.1%
108,215
+13.7%
3.60%
+20.6%
Q4 2021$6,660,000
+49.7%
95,215
+11.7%
2.98%
+47.8%
Q3 2021$4,449,000
-23.2%
85,2150.0%2.02%
-23.1%
Q2 2021$5,795,000
-11.7%
85,2150.0%2.62%
-15.5%
Q1 2021$6,565,000
+28.4%
85,2150.0%3.10%
+5.9%
Q4 2020$5,113,000
+48.1%
85,215
+6.2%
2.93%
+14.2%
Q3 2020$3,453,000
+18.7%
80,215
+14.2%
2.57%
+12.3%
Q2 2020$2,908,000
+11.7%
70,215
+16.6%
2.28%
-9.6%
Q1 2020$2,604,000
-21.9%
60,2150.0%2.53%
-7.7%
Q4 2019$3,335,000
+42.2%
60,215
-10.8%
2.74%
+32.5%
Q3 2019$2,345,000
-13.8%
67,5330.0%2.07%
+1.8%
Q2 2019$2,720,000
+20.0%
67,533
-2.0%
2.03%
+15.8%
Q1 2019$2,267,000
+47.6%
68,900
-6.8%
1.75%
+29.4%
Q4 2018$1,536,000
+62.0%
73,900
+37.1%
1.35%
+82.0%
Q3 2018$948,00053,9000.74%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders